middl
east
respiratori
syndrom
coronaviru
mer
cov
came
attent
emerg
pathogen
caus
sever
respiratori
ill
patient
middl
east
septemb
june
human
case
mer
cov
infect
confirm
includ
death
case
fatal
rate
mer
cov
betacoronaviru
famili
sarscov
share
probabl
origin
bat
anim
reservoir
intermedi
definit
implic
transmiss
limit
humantohuman
transmiss
occur
within
sever
cluster
individu
without
recent
travel
histori
becom
infect
exposur
ill
return
travel
septemb
middl
east
respiratori
syndrom
coronaviru
mer
cov
came
attent
caus
sever
respiratori
ill
patient
middl
east
june
human
case
mer
cov
infect
confirm
result
death
anim
reservoir
intermedi
definit
implic
transmiss
limit
humantohuman
transmiss
occur
within
sever
cluster
case
jordan
saudi
arabia
uk
franc
tunisia
itali
uk
cluster
provid
clearest
evid
humantohuman
transmiss
two
individu
histori
recent
travel
becam
infect
shortli
exposur
rel
infect
mer
cov
return
travel
howev
humantohuman
transmiss
mer
cov
appear
low
close
monitor
healthcar
worker
household
contact
reveal
larg
number
secondari
infect
evid
uk
cluster
suggest
incub
period
mer
cov
rang
day
compar
sar
threequart
infect
occur
men
three
known
infect
women
occur
jordan
uk
egypt
may
reflect
epidemiolog
exposur
arab
countri
figur
illustr
geograph
distribut
confirm
case
date
develop
data
summar
european
centr
diseas
prevent
control
ecdc
mer
cov
betacoronaviru
famili
viru
caus
sar
close
relat
coronavirus
bat
origin
like
sar
probabl
origin
bat
work
zaki
et
al
respiratori
sampl
first
patient
demonstr
effici
viral
replic
monkey
cell
line
apart
sar
coronavirus
replic
well
medium
indirect
immunofluoresc
assay
realtim
polymeras
chain
reaction
rtpcr
respiratori
virus
includ
influenza
parainfluenza
respiratori
syncyti
viru
adenoviru
human
metapneumoviru
paramyxovirus
neg
pcr
assay
coronaviru
famili
indic
expect
fragment
viral
genom
sequenc
phylogenet
analysi
subsequ
reveal
mer
cov
betacoronaviru
genu
lineag
c
unlik
sar
belong
lineag
b
munster
et
al
niaid
nation
institut
allergi
infecti
diseas
success
fulfil
koch
postul
macaqu
model
infect
six
macaqu
monkey
mer
cov
caus
acut
pneumonia
subsequ
reisol
viru
lung
tissu
mer
cov
abl
infect
broad
rang
mammalian
cell
requir
receptor
restrict
sar
primarili
lung
tissu
interest
featur
uk
cluster
coinfect
virus
influenza
index
case
type
parainfluenza
viru
secondari
case
may
highlight
import
biolog
characterist
mer
cov
may
mere
reflect
presenc
multipl
respiratori
virus
circul
ubiquit
winter
nevertheless
find
prompt
world
health
organ
adjust
screen
criteria
current
advis
clinician
test
mer
cov
even
altern
etiolog
identifi
especi
clinic
find
incomplet
explain
etiolog
patient
confirm
mer
cov
present
spectrum
diseas
rang
mild
influenzalik
ill
sever
pneumonia
accompani
respiratori
renal
failur
result
death
death
case
case
fatal
rate
cfr
present
stand
contrast
cfr
sar
high
cfr
probabl
overestim
ill
sever
clinician
tend
pursu
investig
patient
fulmin
infect
respond
convent
therapi
wherea
individu
milder
selflimit
infect
would
necessarili
undergo
extens
test
would
identifi
novel
pathogen
serolog
survey
may
eventu
provid
better
understand
preval
asymptomat
mild
mer
cov
infect
sever
patient
transfer
uk
germani
manag
intens
care
unit
despit
access
excel
tertiari
care
antivir
mechan
ventilatori
support
mani
patient
succumb
overwhelm
infect
although
inform
incomplet
fatal
outcom
gener
older
survivor
median
age
vs
year
date
identifi
patient
strong
epidemiolog
link
travel
arabian
peninsula
exposur
ill
return
travel
region
respiratori
sampl
nose
throat
swab
sputum
endotrach
aspir
bronchial
wash
test
mer
cov
rtpcr
confirm
diagnosi
although
serum
plasma
stool
sampl
sent
case
yield
low
inadequ
case
confid
character
timefram
seroconvers
possibl
like
sar
patient
may
demonstr
requisit
fourfold
rise
titer
week
onset
acut
ill
time
minim
evid
guid
antivir
adjunct
therapi
novel
pathogen
sar
support
care
includ
mechan
ventilatori
support
renal
replac
therapi
may
best
treatment
offer
potenti
harm
therapi
highdos
corticosteroid
avoid
better
evalu
clinic
risk
benefit
studi
shown
interferon
may
benefici
effect
treatment
sar
may
worthwhil
evalu
efficaci
interferon
therapi
treatment
mer
cov
properli
design
random
clinic
trial
infect
becom
widespread
account
first
two
case
discov
read
like
medic
detect
stori
also
underscor
far
intern
medic
scientif
public
health
commun
come
decad
sinc
sar
advanc
sequenc
technolog
social
media
speed
inform
share
intern
health
regul
ihr
framework
prome
network
given
world
improv
prepared
outbreak
novel
pathogen
also
greater
awar
import
infect
control
person
protect
equip
suppli
although
laps
care
vulner
still
discov
pilgrim
travel
singapor
saudi
arabia
hajj
everi
year
octob
schedul
embark
journey
introduct
sar
hand
return
travel
fresh
collect
memori
brace
prime
system
possibl
outbreak
thank
occur
concern
emerg
pathogen
would
spread
via
hajj
prove
unfound
annual
mass
gather
million
muslim
pilgrim
result
global
mer
cov
pandem
gautret
et
al
screen
return
hajj
pilgrim
influenzalik
ill
socal
hajj
cough
found
evid
mer
cov
infect
know
whether
viru
spread
effici
continu
sporad
cluster
today
stand
brink
anoth
zoonot
transmiss
event
china
report
human
case
avian
influenza
infect
includ
death
april
strike
differ
number
case
occur
within
space
month
compar
month
mer
cov
unlik
sar
mer
cov
antivir
medic
could
work
hope
vaccin
develop
brought
commerci
quantiti
within
month
proven
vaccin
antivir
treatment
sar
even
year
newli
discov
mer
cov
without
effect
vaccin
therapeut
classic
public
health
intervent
outbreak
controlisol
quarantin
social
distancingmay
still
remain
effect
countermeasur
stop
new
sar
mer
cov
outbreak
sustain
humantohuman
transmiss
occur
continu
invest
research
prepared
need
etern
vigil
may
inde
price
safeti
emerg
infect
novel
pathogen
